advanced malignant solid neoplasm
Showing 51 - 75 of 93
Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,
Recruiting
- Advanced Bladder Carcinoma
- +34 more
- Atezolizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor
Recruiting
- Advanced Lymphoma
- +13 more
- BET Bromodomain Inhibitor ZEN-3694
- +2 more
-
New Haven, ConnecticutYale University Cancer Center LAO
Jun 29, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Afatinib Dimaleate
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Defactinib Hydrochloride
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Brunswick,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
-
New Brunswick, New Jersey
- +2 more
Jun 28, 2022
Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-OX40 Antibody BMS 986178
- TLR9 Agonist SD-101
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jun 13, 2022
Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib
Completed
- Advanced Malignant Solid Neoplasm
- +6 more
- Afatinib Dimaleate
- +2 more
-
Indianapolis, Indiana
- +1 more
Jun 3, 2022
Patient Considerations of Social Media Account Management After
Recruiting
- Advanced Malignant Solid Neoplasm
- Hematopoietic and Lymphoid System Neoplasm
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
May 24, 2022
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in San Francisco
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Support Group Therapy
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 12, 2022
Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)
Completed
- Advanced Malignant Solid Neoplasm
- Adavosertib
- +5 more
-
Aurora, Colorado
- +7 more
Apr 11, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,
Terminated
- Advanced Malignant Solid Neoplasm
- CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
- Placebo Administration
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 8, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)
Suspended
- Advanced Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
-
Duarte, California
- +8 more
Mar 15, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Trifluridine and Tipiracil Hydrochloride
- Talazoparib Tosylate
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 2, 2022
Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-TGF-beta Monoclonal Antibody SAR-439459
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Advanced Malignant Solid Tumor, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Los Angeles
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Atezolizumab
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 7, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal
Recruiting
- Advanced Lung Carcinoma
- +16 more
- Anti-CTLA4 Monoclonal Antibody BMS-986218
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2022
Advanced Malignant Solid Tumor, Anorexia, Hematopoietic and Lymphoid Cell Tumor Trial in United States (Olanzapine, Megestrol
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Olanzapine
- +2 more
-
Englewood, Colorado
- +67 more
Jan 11, 2022
Advanced Malignant Solid Tumor Trial in Houston (Mindfulness Relaxation, Quality-of-Life Assessment, Questionnaire
Recruiting
- Advanced Malignant Solid Neoplasm
- Mindfulness Relaxation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 16, 2021